As Leerink Partners analyst Ami Fadia put it in a note to clients Wednesday afternoon, Godot is finally here. And that Godot is generic Advair. After a slew of rejections and delays, the FDA approved ...
After the FDA shot down Mylan’s generic Advair for the second time in June, executives said they addressed the “minor deficiencies” and an approval should follow in mid-October. A week into November, ...
Symbicort and Advair are similar brand-name prescription medications that treat asthma and COPD. They contain slightly different active ingredients. Symbicort and Advair are two drugs that treat ...
LONDON (Reuters) - A deadline for U.S. regulators to give a verdict on a generic copy of GlaxoSmithKline's (GSK.L) blockbuster inhaled lung drug Advair has passed with no sign of approval, sparking ...
LONDON (Reuters) - GlaxoSmithKline is likely to escape generic competition to its blockbuster lung drug Advair in the United States this year, after a second application for a cut-price equivalent ...
A study combining Glaxo's blockbuster Advair with Pfizer's Spiriva failed to demonstrate a significant reduction in exacerbations for patients with COPD, or smoker's lung. An exacerbation is a ...
LONDON (Reuters) - GlaxoSmithKline has won another reprieve for its blockbuster Advair lung drug after U.S. regulators delayed approval of a generic copy from Novartis's Sandoz division. The Swiss ...
LONDON, March 16 (Reuters) - Adding GlaxoSmithKline Plc's top-selling drug Advair to Pfizer Inc's Spiriva does not reduce exacerbations in patients with COPD, or smoker's lung, according to new ...
Analysts were surprised to hear that GlaxoSmithKline was handed a "not approvable" letter for the supplemental drug application for the 500/50 strength of Advair Diskus for patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback